Disfunzioni sessuali post-SSRI

Psychother Psychosom. 2020 Apr 7:1-24. doi: 10.1159/000506868. [Epub ahead of print] Acute and Persistent Withdrawal Syndromes Following Discontinuation of Psychotropic Medications. Cosci F 1, 2 , Chouinard G 3 . 1 Department of Health Sciences, University of Florence, Florence, Italy, fiammetta.cosci@unifi.it. 2 Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands, fiammetta.cosci@unifi.it. 3 Clinical Pharmacology and Toxicology Program, McGill University and Mental Health Institute of Montreal Fernand Seguin Research Centre, University of Montreal, Montreal, Québec, Canada. Abstract Studies on psychotropic medications decrease, discontinuation, or switch have uncovered withdrawal syndromes. The present overview aimed at analyzing the literature to illustrate withdrawal after decrease, discontinuation, or switch of psychotropic medications based on the drug class (i.e., benzodiazepines, nonbenzodiazepine benzodi

Journal of Urology   Sexual Function/Dysfunction: Evaluation II (MP78) 1 Apr 2020 MP78-15 POST-SSRI SEXUAL DYSFUNCTION (PSSD): TEN YEAR RETROSPECTIVE CHART REVIEW Ahad Waraich* ,  Channing Clemons ,  Roma Ramirez ,  Jessica Yih ,  Sue Goldstein , and  Irwin Goldstein https://doi.org/10.1097/JU.0000000000000964.015 Abstract INTRODUCTION AND OBJECTIVE: Post-SSRI Sexual Dysfunction (PSSD) is a poorly understood, iatrogenic, distressing, multidimensional sexual health condition that occurs in young patients and includes ED, hypoactive sexual desire disorder (HSDD), orgasmic dysfunction, and/or decreased genital sensation, that despite discontinuation of SSRI/SNRI agents, persists > 6 mo. We wished to better understand PSSD, the frequency/severity of symptoms, and the results of diagnostic testing. METHODS: A retrospective review was performed of charts from 2009 to 2019. Patients reported their symptoms, completed the IIEF, and underwent a gr